IL114459A0 - Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases - Google Patents
Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseasesInfo
- Publication number
- IL114459A0 IL114459A0 IL11445995A IL11445995A IL114459A0 IL 114459 A0 IL114459 A0 IL 114459A0 IL 11445995 A IL11445995 A IL 11445995A IL 11445995 A IL11445995 A IL 11445995A IL 114459 A0 IL114459 A0 IL 114459A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- effectiveness
- monitoring
- detecting
- cell mediated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11445995A IL114459A0 (en) | 1995-07-05 | 1995-07-05 | Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases |
IL12275696A IL122756A (en) | 1995-07-05 | 1996-07-02 | Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
EP96923689A EP0847281B1 (en) | 1995-07-05 | 1996-07-02 | Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
DE69627161T DE69627161T2 (de) | 1995-07-05 | 1996-07-02 | Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen |
JP50531897A JP3905126B2 (ja) | 1995-07-05 | 1996-07-02 | T細胞媒介疾患の治療の効力を検出又は監視する方法 |
AU64543/96A AU6454396A (en) | 1995-07-05 | 1996-07-02 | Method for detecting or monitoring the effectiveness of treament of t cell mediated diseases |
AT96923689T ATE235922T1 (de) | 1995-07-05 | 1996-07-02 | Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen |
PCT/US1996/011374 WO1997002052A1 (en) | 1995-07-05 | 1996-07-02 | Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
US08/973,782 US6309847B1 (en) | 1995-07-05 | 1996-07-02 | Method for detecting or monitoring the effectiveness of treatment of T cell mediated diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11445995A IL114459A0 (en) | 1995-07-05 | 1995-07-05 | Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL114459A0 true IL114459A0 (en) | 1995-11-27 |
Family
ID=11067728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11445995A IL114459A0 (en) | 1995-07-05 | 1995-07-05 | Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0847281B1 (ja) |
JP (1) | JP3905126B2 (ja) |
AT (1) | ATE235922T1 (ja) |
AU (1) | AU6454396A (ja) |
DE (1) | DE69627161T2 (ja) |
IL (1) | IL114459A0 (ja) |
WO (1) | WO1997002052A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022697A (en) * | 1996-11-29 | 2000-02-08 | The Regents Of The University Of California | Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
AU2003209623A1 (en) * | 2002-02-19 | 2003-09-09 | Yeda Research And Development Co. Ltd. | Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation |
US8691772B2 (en) * | 2005-01-04 | 2014-04-08 | Yeda Research And Development Co. Ltd. | HSP60, HSP60 peptides and T cell vaccines for immunomodulation |
US20070031482A1 (en) * | 2005-08-02 | 2007-02-08 | Ceramoptec Industries, Ind. | PDT treatment method for cellulites and cosmetic use |
JP4283812B2 (ja) * | 2006-01-06 | 2009-06-24 | 財団法人工業技術研究院 | 重症筋無力症の診断方法およびそのキット |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006630A1 (en) * | 1994-08-26 | 1996-03-07 | The Regents Of The University Of California | Methods and compositions for modulating a t cell response |
-
1995
- 1995-07-05 IL IL11445995A patent/IL114459A0/xx unknown
-
1996
- 1996-07-02 JP JP50531897A patent/JP3905126B2/ja not_active Expired - Fee Related
- 1996-07-02 WO PCT/US1996/011374 patent/WO1997002052A1/en active IP Right Grant
- 1996-07-02 EP EP96923689A patent/EP0847281B1/en not_active Expired - Lifetime
- 1996-07-02 AU AU64543/96A patent/AU6454396A/en not_active Abandoned
- 1996-07-02 DE DE69627161T patent/DE69627161T2/de not_active Expired - Lifetime
- 1996-07-02 AT AT96923689T patent/ATE235922T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP0847281A1 (en) | 1998-06-17 |
DE69627161D1 (de) | 2003-05-08 |
DE69627161T2 (de) | 2004-02-19 |
JP2001520740A (ja) | 2001-10-30 |
EP0847281B1 (en) | 2003-04-02 |
ATE235922T1 (de) | 2003-04-15 |
WO1997002052A1 (en) | 1997-01-23 |
AU6454396A (en) | 1997-02-05 |
JP3905126B2 (ja) | 2007-04-18 |
EP0847281A4 (en) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1008619A1 (nl) | Werkwijze voor het meten en aangeven van de mate waarin een persoon beperkt is in activiteiten van het dagelijks leven. | |
EP1113385A3 (en) | Device and method for sensing data input | |
EP0653718A3 (de) | Vorrichtung und Verfahren zur Erfassung körperspezifischer Messdaten. | |
DE69940470D1 (de) | Vorrichtung und verfahren für die thermometrie | |
IL126544A0 (en) | Analyte assay using particulate labels | |
CY1108397T1 (el) | Αντι-ccr4 αντισωμα και θραυσμα αυτου | |
EP0445618A3 (en) | Device and procedure to measure without contact the surface-contour of an object | |
EP0702978A3 (en) | Apparatus for treating obstructive sleep apnea | |
EP0311439A3 (en) | Ozone gas sensor and ozone gas detecting device having ozone gas sensor | |
PT1148816E (pt) | Protecções de dentes e métodos de detecção do ranger dos dentes | |
EP1178536A3 (en) | Image reading apparatus | |
DE68915372D1 (de) | Gerät zum Wiegen und zur Grössenmessung von Personen. | |
IL114459A0 (en) | Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases | |
DE69127495D1 (de) | Erkennungseinheit und Gerät zur Erkennung und Beurteilung in dem die Einheit verwendet ist | |
FR2651036B1 (fr) | Dispositif capteur delivrant des indications de pression et de temperature | |
WO2001029070A8 (en) | Modulation of t cell differentiation for the treatment of t helper cell mediated diseases | |
DK0984723T3 (da) | Kardiovaskulær monitor | |
EP0296769A3 (en) | Ophthalmic disease detection method and apparatus | |
ATA2289A (de) | Vorrichtung zur messung des blutdruckes am menschlichen oder tierischen koerper | |
JPH03222941A (ja) | 入眠判定装置 | |
EP0738103A3 (de) | Verfahren und Vorrichtung zum vollautomatischen Handhaben von elektrisch zu prüfenden Prüflingen | |
EP0782863A4 (en) | ANTIBODY REAGENT TO DETECT AND USE THE ANEURYSMA DISSECAN OF THE AORTA | |
CN218010369U (zh) | 一种医用中医针灸拔针检测仪 | |
AU2001266983A1 (en) | Adjuvants and processes to induce a specific type of immune response | |
FR2595670B3 (fr) | Dispositif permettant de delivrer un par un des objets mis en vrac ayant des formes et des tailles variees |